Skip to main content

Table 7 Association between DNA methylation with the MTHFR C677T genotype and the risk of EPL and ESCC

From: MTHFR C677T genetic polymorphism in combination with serum vitamin B2, B12 and aberrant DNA methylation of P16 and P53 genes in esophageal squamous cell carcinoma and esophageal precancerous lesions: a case–control study

DNA methylation

EPL [OR (95% CI)a, p for interaction]

ESCC [OR (95% CI)a, p for interaction]

CC

CT

TT

CC

CT

TT

p16U

1.00 (reference)

0.88 (0.50–1.53)

0.640

1.32 (0.62–2.80)

0.474

1.00 (reference)

1.03 (0.56–1.90)

0.921

0.66 (0.25–1.77)

0.409

p16 M

1.04 (0.58–1.85)

0.900

1.98 (1.01–3.89)

0.048

17.79 (2.26–140.22)

0.006

1.91 (1.95–3.47)

0.033

4.86 (2.48–9.50)

< 0.001

20.40 (2.53–164.81)

0.005

p53U

1.00 (reference)

0.90 (0.46–1.40)

0.441

1.25 (0.59–2.63)

0.558

1.00 (reference)

0.90 (0.50–1.60)

0.710

0.49 (0.19–1.31)

0.156

p53 M

0.77(0.43–1.37)

0.369

1.56(0.79–3.09)

0.205

13.28(1.67–105.70)

0.015

1.15(0.64–2.06)

0.643

3.27(1.68–6.34)

< 0.001

15.24(1.90–122.62)

0.010

  1. U unmethylated, M methylated
  2. aAdjusted for gender, age, tobacco smoking and alcoholic drinking